Companies implementing Model-Informed Drug Development (MIDD)

Model-informed drug development (MIDD) employs quantitative modeling techniques throughout the drug development lifecycle to support decisions such as dose selection, efficacy justification, trial design, and policy guidance.

List of companies that implement Model-Informed Drug Development (MIDD)

CompanyCountryIndustryEmployeesRevenueTechnologies
Country flag

United Kingdom

Pharmaceutical Manufacturing

79k

Model-Informed Drug Development (MIDD)

Country flag

United Kingdom

Pharmaceutical Manufacturing

98k

$35B

Model-Informed Drug Development (MIDD)

Country flag

United States

Pharmaceutical Manufacturing

103k

$100B

Model-Informed Drug Development (MIDD)

Country flag

United States

Biotechnology Research

21k

$26B

Model-Informed Drug Development (MIDD)

Country flag

France

Pharmaceutical Manufacturing

92k

$46B

Model-Informed Drug Development (MIDD)

Country flag

United States

Biotechnology Research

9.2k

$10B

Model-Informed Drug Development (MIDD)

Country flag

United States

Pharmaceutical Manufacturing

41k

$28B

Model-Informed Drug Development (MIDD)

Country flag

United States

Pharmaceutical Manufacturing

39k

$46B

Model-Informed Drug Development (MIDD)

Country flag

United States

Biotechnology Research

15k

$27B

Model-Informed Drug Development (MIDD)

Country flag

United States

Government Administration

10k

Model-Informed Drug Development (MIDD)

Showing top companies out of 282 that implement Model-Informed Drug Development (MIDD). Get the full list on TheirStack.

Frequently asked questions